Submission Details
| 510(k) Number | K193650 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 30, 2019 |
| Decision Date | September 14, 2021 |
| Days to Decision | 624 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K193650 is an FDA 510(k) clearance for the LIAISON Ferritin, a Ferritin, Antigen, Antiserum, Control (Class II — Special Controls, product code DBF), submitted by DiaSorin, Inc. (Stillwater, US). The FDA issued a Cleared decision on September 14, 2021, 624 days after receiving the submission on December 30, 2019. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5340.
| 510(k) Number | K193650 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 30, 2019 |
| Decision Date | September 14, 2021 |
| Days to Decision | 624 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | DBF — Ferritin, Antigen, Antiserum, Control |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5340 |